航天發展(000547.SZ):一季度同比收入下降主要由於重要子企業新籤合同較上年下降
格隆匯5月5日丨有投資者在投資者互動平台向航天發展(000547.SZ)提問,“貴公司連續兩個季度大額虧損,是什麼原因導致的?公司是否能恢復盈利能力?”
航天發展回覆稱,公司一季度同比收入下降主要由於重要子企業新籤合同較上年下降,當期項目進展不及預期,導致本期營業收入較上年同期大幅下降,由於收入大幅下降,部分子公司人員結構及薪酬調整人工增加,導致本期歸母淨利較上年同期大幅下降。公司已制定年度經營計劃,強化技術研發攻關能力,大力開拓市場,爭取新籤合同,全力保生產、促交付。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.